RT Journal Article
SR Electronic
T1 Multicountry genomic analysis underscores regional cholera spread in Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.15.24317392
DO 10.1101/2024.11.15.24317392
A1 Mboowa, Gerald
A1 Matteson, Nathaniel Lucero
A1 Tanui, Collins Kipngetich
A1 Kasonde, Mpanga
A1 Kamwiziku, Guyguy Kusanzangana
A1 Akanbi, Olusola Anuoluwapo
A1 Chitio, Jucunú Johane Elias
A1 Kagoli, Mathews
A1 Essomba, René Ghislain
A1 Ayitewala, Alisen
A1 Ssewanyana, Isaac
A1 Ngo Bitoungui, Valentina Josiane
A1 Amuri, Adrienne Aziza
A1 Azman, Andrew S
A1 Babatunde, Olajumoke Atinuke
A1 Akenji, Blaise Mboringong
A1 Broban, Anaïs
A1 Malembaka, Espoir Bwenge
A1 Ongole, Francis
A1 Chukwu, Chimaobi Emmanuel
A1 Ismael, Nália
A1 Kapona, Otridah
A1 Laurindo, Osvaldo
A1 Mbala, Placide Kingebeni
A1 Etoundi Mballa, Georges Alain
A1 Miambo, Imelda Carlos Zulfa
A1 Mwanyongo, Alex Ansaye
A1 Najjuka, Grace
A1 Mutale, Joseph
A1 Musonda, Kunda
A1 Niyonzima, Allan Muruta
A1 Nyenje, Mirriam Ethel
A1 Popoola, Michael
A1 Shempela, Doreen Mainza
A1 Medi Sike, Christiane
A1 Sitoe, Sofião Manjor
A1 Wanjohi, Dorcas Waruguru
A1 Welo, Placide Okitayemba
A1 Yelewa, Mtisunge
A1 Yennan, Sebastian
A1 Ziba, Lucius
A1 CholGEN Consortium
A1 Bitilinyu-Bangoh, Joseph Ephram
A1 Chilengi, Roma
A1 Hadja, Hamsatou
A1 Idris, Jide
A1 Langa, José Paulo Maurício
A1 Mukadi-Bamuleka, Daniel
A1 Nabadda, Susan
A1 Debes, Amanda K
A1 Sack, David A
A1 Kaseya, Jean
A1 Tebeje, Yenew Kebede
A1 Wohl, Shirlee
A1 Tessema, Sofonias Kifle
YR 2024
UL http://medrxiv.org/content/early/2024/11/15/2024.11.15.24317392.abstract
AB Cholera remains a significant public health burden in many countries in sub-Saharan Africa, though the exact mechanisms of bacterial emergence and spread remain largely undefined. We generated genomic data from 728 Vibrio cholerae O1 isolates predominantly collected between 2019-2024 to create the largest dataset of V. cholerae genomes sequenced locally in Africa. This dataset enabled us to interrogate recent patterns of spread, including the rapid circulation of the AFR15 lineage associated with unusually large outbreaks in Southern Africa. We provide evidence for the movement of the AFR15 lineage into new African Member States and confirm previously observed differences in V. cholerae transmission dynamics in West versus East Africa, though cross-border transmission is prevalent on both sides of the continent. Despite observed differences, evolutionary processes are similar across lineages and we find no evidence for significant changes in antimicrobial resistance genotypes. Overall, our findings emphasize the importance of regionally coordinated cross-border surveillance and interventions, while also demonstrating the critical role of locally generated genomic data in understanding the spread of cholera in Africa.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Bill & Melinda Gates Foundation (INV-047157 and INV-047156).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research utilized samples collected through routine national surveillance programs and all data and samples were anonymized to ensure the privacy and confidentiality of the individuals involved. The use of these samples was approved by respective Ethical Review Boards/Institutions in each country, ensuring that the research adhered to the highest ethical standards and legal requirements. In Cameroon, ethical approval was granted by the National Committee on Ethics in Research for Human Health (2024/02/1640/CE/CNERSH/SP). In DRC, ethical approval was granted by the Board of the Ethics Committee of the School of Public Health at the University of Kinshasa (ESP/CE/148/2023 and ESP/CE/149/2023). In Malawi, this work was approved by the National Health Sciences Research Committee (Protocol #867). In Mozambique, ethical approval was granted by the National Bioethics Committee for Health (335/CNBS/23). In Nigeria, ethical approval was not required as it is based on data from Nigeria's national surveillance program, collected by the Nigeria Centre for Disease Control. In Uganda, ethical approval was granted by the Uganda Ministry of Health National Health Laboratory Services (UNHL-2024-88).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesRaw sequencing reads are available on NCBI under the BioProject accession ID PRJNA1145341 and Sequence Read Archive accession IDs are provided in Supplemental Data 1. Accession IDs for the publicly available sequences acquired from NCBI or VibrioWatch are provided in Supplemental Data 2. https://github.com/CholGen/RegionalAnalysis-2024 https://doi.org/10.5281/zenodo.14170938